Replies to post #5833 on Secure Point Technologies Inc (fka IMSCQ)

[b9molecule]

AG25

If you follow the Form 4 filings at sec.gov you will see that over the past year several officers exercised options that they were granted as part of their incentive packages. in order to do this they need to pay the price of the option to get the shares. often, upon exercising options, officers will sell some of the new shares to offset the cost of the option exercise. this is what happened in Implant's case.

We on the msg board covered these filings extensively as they occurred, and determined that most of the common shares remained in the hands of officers, and they only sold enough to cover the cost of the option exercise and perhaps the tax owed on that transaction. this is a nominally bullish scenario, as they could have sold all of their common shares. as it stands now, they are more aligned with common shareholders, but they still have a lot of options outstanding. I hope this helps.